医学
肢端肥大症
垂体瘤
垂体腺瘤
揭穿
小心等待
外科
神经外科
溢乳
放射治疗
腺瘤
神秘的
内科学
病理
癌症
生长激素
激素
催乳素
前列腺癌
卵巢癌
替代医学
作者
Philippe Chanson,Peter Wolf
出处
期刊:Presse Medicale
[Elsevier BV]
日期:2021-10-28
卷期号:50 (4): 104086-104086
被引量:20
标识
DOI:10.1016/j.lpm.2021.104086
摘要
Clinically non functioning pituitary adenomas (NFPAs) include all pituitary adenomas that are not hormonally active. They are not associated with clinical syndromes such as amenorrhea-galactorrhea (prolactinomas), acromegaly, Cushing's disease or hyperthyroidism (TSH-secreting adenomas) and are therefore usually diagnosed by signs and symptoms related to a mass effect (headache, visual impairment, sometimes pituitary apoplexy), but also incidentally. Biochemical work up often documents several pituitary insufficiencies. In histopathology, the majority of NFPAs are gonadotroph. In the absence of an established medical therapy, surgery is the mainstay of treatment, unless contraindicated or in particular situations (e.g. small incidentalomas, distance from optic pathways). Resection, generally via a trans-sphenoidal approach (with the help of an endoscope), should be performed by a neurosurgeon with extensive experience in pituitary surgery, in order to maximize the chances of complete resection and to minimize complications. If a tumor remnant persists, watchful waiting is preferred to routine radiotherapy, as long as the tumor residue does not grow and is distant from the optic pathways. NFPA can sometimes recur even after complete resection, but predicting the individual risk of tumor remnant progression is difficult. Postoperative irradiation is only considered in case of residual tumor growth or relapse, due to its potential side effects.
科研通智能强力驱动
Strongly Powered by AbleSci AI